Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations.
Michael A. Caligiuri(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Clara D. Bloomfield(North Shore University Hospital), Maria R. Baer(University of Maryland, Baltimore), Krzysztof Mrózek(The Ohio State University), Maurice Barcos(Roswell Park Comprehensive Cancer Center), Steven A. Schichman(Central Arkansas Veterans Healthcare System), Stanley R. Frankel(Georgetown University), Matthew P. Strout(Yale Cancer Center), Geoffrey P. Herzig(Washington University in St. Louis), Cario M. Croce
PubMed
January 15, 1994
Cited by 162
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k